Oscar Health, Inc. Interest Expense Nonoperating
Oscar Health, Inc. (OSCR) reported Interest Expense Nonoperating of $4.71 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-07
- Oscar Health, Inc. interest expense nonoperating for the quarter ending 2026-06-30 was $4.71M, a 19.46% decline year-over-year.
- Oscar Health, Inc. interest expense nonoperating for the quarter ending 2026-03-31 was $5.38M, a 10.19% decline year-over-year.
- Oscar Health, Inc. interest expense nonoperating for the quarter ending 2025-12-31 was -$1.10M, a 118.20% decline year-over-year.
- Oscar Health, Inc. interest expense nonoperating for the quarter ending 2025-09-30 was $6.86M, a 17.92% increase year-over-year.
- Oscar Health, Inc. interest expense nonoperating for fiscal 2025 was $17.60M, a 25.84% decline from fiscal 2024.
- Oscar Health, Inc. interest expense nonoperating for fiscal 2024 was $23.73M, a 3.53% decline from fiscal 2023.
- Oscar Health, Inc. interest expense nonoperating for fiscal 2023 was $24.60M, a 8.75% increase from fiscal 2022.
- Oscar Health, Inc. interest expense nonoperating for fiscal 2022 was $22.62M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.71M 10-Q · filed 2026-08-07 | $10.09M 10-Q · filed 2026-08-07 | $8.99M derived: sum of 3 quarters · filed 2026-08-07 | $15.85M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $5.38M 10-Q · filed 2026-05-07 | $4.29M derived: sum of 2 quarters · filed 2026-05-07 | $11.14M derived: sum of 3 quarters · filed 2026-05-07 | $16.99M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.76M derived: sum of 2 quarters · filed 2026-02-13 | $11.61M derived: sum of 3 quarters · filed 2026-08-07 | $17.60M 10-K · filed 2026-02-13 |
| 2025-09-30 | $6.86M 10-Q · filed 2025-11-06 | $12.70M derived: sum of 2 quarters · filed 2026-08-07 | $18.70M 10-Q · filed 2025-11-06 | $24.72M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $5.85M 10-Q · filed 2026-08-07 | $11.84M 10-Q · filed 2026-08-07 | $17.87M derived: sum of 3 quarters · filed 2026-08-07 | $23.68M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $5.99M 10-Q · filed 2026-05-07 | $12.02M derived: sum of 2 quarters · filed 2026-05-07 | $17.84M derived: sum of 3 quarters · filed 2026-05-07 | $23.83M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $6.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $11.84M derived: sum of 2 quarters · filed 2026-02-13 | $17.83M derived: sum of 3 quarters · filed 2026-02-13 | $23.73M 10-K · filed 2026-02-13 |
| 2024-09-30 | $5.82M 10-Q · filed 2025-11-06 | $11.81M derived: sum of 2 quarters · filed 2025-11-06 | $17.71M 10-Q · filed 2025-11-06 | $23.93M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $5.99M 10-Q · filed 2025-08-07 | $11.89M 10-Q · filed 2025-08-07 | $18.11M derived: sum of 3 quarters · filed 2026-02-13 | $24.24M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $5.90M 10-Q · filed 2025-05-08 | $12.12M derived: sum of 2 quarters · filed 2026-02-13 | $18.25M derived: sum of 3 quarters · filed 2026-02-13 | $24.37M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $6.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $12.35M derived: sum of 2 quarters · filed 2026-02-13 | $18.47M derived: sum of 3 quarters · filed 2026-02-13 | $24.60M 10-K · filed 2026-02-13 |
| 2023-09-30 | $6.13M 10-Q · filed 2024-11-07 | $12.25M derived: sum of 2 quarters · filed 2024-11-07 | $18.39M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $6.12M 10-Q · filed 2024-08-07 | $12.26M 10-Q · filed 2024-08-07 | ||
| 2022-12-31 | $22.62M 10-K · filed 2025-02-20 |